(Q36874668)

English

A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy

scientific article published on 29 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Escherichia coli

0 references

3

object named as

A W Burks

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

R A Wood

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

S H Sicherer

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

A Grishin

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

A K Henning

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

R Lindblad

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

D Stablein

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

H A Sampson

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

29 April 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

68

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

803-808

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Oral immunotherapy for treatment of egg allergy in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

The safety and efficacy of sublingual and oral immunotherapy for milk allergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Quality of life in food allergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Future therapies for food allergies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Epidemiology of food allergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Safety of a peanut oral immunotherapy protocol in children with peanut allergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Allergenic characteristics of a modified peanut allergen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Fatalities due to anaphylactic reactions to foods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

29 September 2017

Peanut oral immunotherapy is not ready for clinical use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

27 June 2018

Oral peanut immunotherapy in children with peanut anaphylaxis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

27 June 2018

Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

4 September 2018

Adverse reactions during peanut oral immunotherapy home dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

4 September 2018

Further fatalities caused by anaphylactic reactions to food, 2001-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

4 September 2018

Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

4 September 2018

Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

4 September 2018

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3663889

4 September 2018

Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23621498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23621498

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/ALL.12158

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36874668&oldid=2088020702"